105 related articles for article (PubMed ID: 38743987)
1. CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway.
Li Z; Yan G; Yang M; Liu X; Lian Y; Sun M; Pan W
Transl Oncol; 2024 Jul; 45():101992. PubMed ID: 38743987
[TBL] [Abstract][Full Text] [Related]
2. CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN.
Li W; Lei T; Song X; Deng C; Lu J; Zhang W; Kuang Z; He Y; Zhou Q; Luo Z; Mo F; Yang H; Hang J; Xiao B; Li L
J Recept Signal Transduct Res; 2022 Dec; 42(6):588-598. PubMed ID: 36043996
[TBL] [Abstract][Full Text] [Related]
3. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
4. Abelson interactor 1 splice isoform-L plays an anti-oncogenic role in colorectal carcinoma through interactions with WAVE2 and full-length Abelson interactor 1.
Li K; Peng YF; Guo JZ; Li M; Zhang Y; Chen JY; Lin TR; Yu X; Yu WD
World J Gastroenterol; 2021 Apr; 27(15):1595-1615. PubMed ID: 33958846
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
6. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
7. Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.
Steinestel K; Brüderlein S; Steinestel J; Märkl B; Schwerer MJ; Arndt A; Kraft K; Pröpper C; Möller P
PLoS One; 2012; 7(7):e40671. PubMed ID: 22808230
[TBL] [Abstract][Full Text] [Related]
8. CLDN8 promotes colorectal cancer cell proliferation, migration, and invasion by activating MAPK/ERK signaling.
Cheng B; Rong A; Zhou Q; Li W
Cancer Manag Res; 2019; 11():3741-3751. PubMed ID: 31118793
[TBL] [Abstract][Full Text] [Related]
9. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
[TBL] [Abstract][Full Text] [Related]
10. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract][Full Text] [Related]
12. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
[TBL] [Abstract][Full Text] [Related]
13. FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.
Pan F; Li M; Chen W
Am J Transl Res; 2018; 10(5):1522-1530. PubMed ID: 29887965
[TBL] [Abstract][Full Text] [Related]
14. EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
Front Oncol; 2019; 9():643. PubMed ID: 31380280
[No Abstract] [Full Text] [Related]
15. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
Guo X; Li Y; Chen X; Sun B; Guo X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation.
Xiao Z; Wei Z; Deng D; Zheng Z; Zhao Y; Jiang S; Zhang D; Zhang LJ; Fan M; Chen S; Wang S; Ding Y; Ye Y; Jiao H
Cancer Cell Int; 2020; 20():50. PubMed ID: 32082080
[TBL] [Abstract][Full Text] [Related]
17. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
18. MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation.
Zhang Y; Li QS; Liu HL; Tang HT; Yang HL; Wu DQ; Huang YY; Li LC; Liu LH; Li MX
J Exp Clin Cancer Res; 2023 Aug; 42(1):219. PubMed ID: 37620897
[TBL] [Abstract][Full Text] [Related]
19. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway.
Liu R; Deng P; Zhang Y; Wang Y; Peng C
World J Surg Oncol; 2021 Feb; 19(1):51. PubMed ID: 33596920
[TBL] [Abstract][Full Text] [Related]
20. The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells.
Du WY; Lu ZH; Ye W; Fu X; Zhou Y; Kuang CM; Wu JX; Pan ZZ; Chen S; Liu RY; Huang WL
Chin J Cancer; 2017 Jan; 36(1):11. PubMed ID: 28088228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
